98%
921
2 minutes
20
Objective: This study aimed to report the 2 year outcomes obtained with the E-nside endograft (Artivion) for the treatment of complex abdominal aortic aneurysm (cAAA) and thoraco-abdominal aortic aneurysm (TAAA).
Methods: This was a prospective, multicentre study. Data from the multicentre ItaliaN Branched Registry of E-nside EnDograft (INBREED) were analysed. Primary endpoints were aortic related death, main endograft instability, and target vessel (TV) instability. Secondary endpoints were any re-intervention, TV related patency and endoleaks, and aneurysm sac dynamics at 1 year.
Results: There were 206 patients (111 TAAAs, 53.9%; 95 cAAAs, 46.1%), accounting for 795 TVs successfully incorporated through an inner branch; 28.6% had an urgent repair. At 2 years, overall survival was 90.3% (95% confidence interval [CI] 87 - 97%); freedom from aortic related death was 96% (95% CI 94 - 100%), and freedom from endograft instability related to proximal seal failure was 97.6% (95% CI 95 - 100%). Freedom from TV instability was 95.9% (95% CI 93 - 97%) and freedom from re-intervention was 98% (95% CI 96 - 99%). For renal arteries, primary patency was 96.1% (95% CI 93 - 98%) and freedom from endoleak was 99.4% (95% CI 98 - 100%). At 1 year, 26% of cases had sac regression and 68% remained stable.
Conclusion: The E-nside endograft demonstrated good 2 year outcomes in the treatment of cAAA and TAAA. It safely and effectively prevented aneurysm related death and guaranteed low TV instability. During planning, attention should be given to the proximal sealing zone to prevent graft instability during follow up.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejvs.2025.08.042 | DOI Listing |
Eur J Vasc Endovasc Surg
August 2025
Division of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.
Objective: This study aimed to report the 2 year outcomes obtained with the E-nside endograft (Artivion) for the treatment of complex abdominal aortic aneurysm (cAAA) and thoraco-abdominal aortic aneurysm (TAAA).
Methods: This was a prospective, multicentre study. Data from the multicentre ItaliaN Branched Registry of E-nside EnDograft (INBREED) were analysed.
J Vasc Surg
June 2025
Division of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.
Objective: To report the impact of the learning curve on the outcomes of branched endovascular aortic repair using an off-the-shelf preloaded inner branch device (E-nside).
Methods: Data from a physician-initiated national multicenter registry, including patients treated with E-nside endograft (INBREED [ItaliaN Branch Registry of E-nside EnDograft]) were collected prospectively (2020-2024). End points were early (30-day) technical success, mortality, major adverse events (MAEs), and 2-year freedom from endograft instability and target vessel instability.
Eur J Vasc Endovasc Surg
April 2025
Università Cattolica del Sacro Cuore, Rome, Italy; Unit of Vascular Surgery, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.
Objective: This study aimed to evaluate the early and midterm outcomes of endovascular repair of aortic dissection (AD) using a new pre-cannulated, inner branch based, off the shelf stent graft (E-nside; JOTEC, CryoLife, Inc.).
Methods: Data from an international multicentre registry on patients treated with the E-nside endograft for AD were analysed.
Eur J Vasc Endovasc Surg
June 2025
Division of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.
Objective: To investigate outcomes of an off the shelf pre-loaded inner branched endograft (E-nside) for the treatment of juxtarenal and pararenal abdominal aortic aneurysms (JP-AAAs).
Methods: Data from a multicentre registry (INBREED), including patients treated with the E-nside endograft, were collected and analysed prospectively. Patients treated for JP-AAA were included.
Eur J Vasc Endovasc Surg
June 2025
Vascular and Endovascular Surgery Division, "San Bortolo" Hospital, ULSS 8 Berica, Vicenza, Italy.
Objective: The aim of this study was to assess the results of an off the shelf inner branched thoraco-abdominal endograft for treating aortic pathologies, with a specific focus on comparing outcomes between antegrade and retrograde approaches for target vessel (TV) cannulation.
Methods: This was a national, physician initiated, multicentre, observational study. Data from a registry on patients treated with the E-nside endograft were gathered prospectively.